This new 363-page report from VPGMarketResearch.com provides analysis of the European enteric disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.... Research Beam Model: Research Beam Product ID: 221456 6100 USD New
2015 Opportunities in the European Enteric Diseases Diagnostic Testing Market

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

2015 Opportunities in the European Enteric Diseases Diagnostic Testing Market

 
  • Category : Diagnostic and Biotech
  • Published On : April  2015
  • Pages : 363
 
 

This new 363-page report from VPGMarketResearch.com provides analysis of the European enteric disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. 



About this Report



This report presents detailed analysis of the Enteric Disease market in Europe (France, Germany, Italy, Spain, UK).  Current scientific views on epidemiology and etiology are presented for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia.  The report provides test volume and sales forecasts and market segment, including:



     - Hospitals

     - Commercial/Private Labs

     - Physician Offices

     - Public Health Labs      



In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of enteric disease diagnostic products, by test and country.  Also, the report:



     -  Examines market applications of Molecular Diagnostics,  

        Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;



     -  Reviews features and operating characteristics of major analyzers used 

        for enteric disease testing;



     -  Profiles key suppliers and potential market entrants developing innovative

        technologies and products; and



     -  Analyzes emerging opportunities, alternative market penetration strategies, 

         market entry barriers/risks, and strategic planning issues.



Methodology



The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in Europe.



In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group’s proprietary data files was conducted.



Contains 363pages and 71 tables